BioSpace News Archive

KELOWNA, BC , Feb. 24, 2020 /PRNewswire/ - Valens GroWorks Corp. (TSXV: VLNS) (OTCQX: VLNCF) (the " Company ", " Valens " or " The Valens Company "), a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, is pleased to report its financial results for its fourth quarter and fiscal year ended N

Orthofix Medical Inc., a global medical device company focused on musculoskeletal healing products, announces support for the continued U.S. Food and Drug Administration Class III designation for Bone Growth Stimulators to ensure patient safety and therapy efficacy.

Feb. 24, 2020 23:30 UTC Akili Announces Publication of AKL-T01 ADHD Pivotal Study Results in the Lancet Digital Health First publication of complete results shows improvement across both objective measures of attention and parent and clinician ratings of ADHD symptoms and functional impairments Study results suggest AKL-T01 could play an important role in the treatment of pediatric ADHD, directly targeting attention impairments BOSTON--( BUSINESS WIRE )-- Akili In

This statement is attributed to: FDA Commissioner Stephen M. Hahn, M.D., and Judy McMeekin, Pharm.D., Acting Associate Commissioner for Regulatory Affairs

Perrigo Company plc and its partner, Catalent Pharma Solutions, today announced that the U.S. Food and Drug Administration has approved Perrigo’s abbreviated new drug application for generic albuterol sulfate inhalation aerosol, the first AB-rated generic version of ProAir® HFA*.

Agency Supports Development of Complex Generic Drugs to Improve Competition and Access to More Affordable Medicines

The increasing complex nature of emergencies requires a much more sophisticated and agile approach to humanitarian action and assistance.

Vir Biotechnology, Inc. announced that George Scangos, Ph.D., Chief Executive Officer will present at the 40th Annual Cowen Healthcare Conference on Tuesday, March 3rd at 11:20 a.m. ET.

Shuwen Biotech Co. Ltd., a China-based leader in innovative diagnostics announced that PerkinElmer, Inc. will distribute Shuwen’s breakthrough diagnostic test for preeclampsia in over 100 countries around the globe, accounting for over 120 million pregnancies annually.

United Therapeutics Corporation (NASDAQ: UTHR) today announced that preliminary analysis indicates that the INCREASE clinical study of Tyvaso® (treprostinil) Inhalation Solution in patients suffering from World Health Organization (WHO)